Presentation, diagnosis and management of tuberculosis in HIV-infected children in the UK

HIV Medicine

Volumn 9, Issue 5, 2008, Pages 277-284

  Cohen, J M ^a,b   Whittaker, E ^a   Walters, S ^a   Lyall, H ^a   Tudor Williams, G ^a   Kampmann, B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coinfection; HIV; Therapeutic drug monitoring; Tuberculosis

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LOPINAVIR; NEVIRAPINE; PYRAZINAMIDE; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BONE MARROW SUPPRESSION; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATITIS; DIAGNOSTIC TEST; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG MONITORING; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION RISK; LUNG TUBERCULOSIS; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; TUBERCULOSIS; UNITED KINGDOM;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TUBERCULOSIS; VIRAL LOAD;

EID: 42049099315     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00559.x     Document Type: Article

References (27)

1. Cotton MF, Schaaf HS, Hesseling AC, Madhi SA. HIV and childhood tuberculosis: The way forward. Int J Tuberc Lung Dis 2004; 8: 675-682.
2. UNAIDS. 2007 Report on the global AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS), 2007.
3. Swaminathan S, Nandini KS, Hanna LE, Somu N, Narayanan PR, Barnes PF. T-lymphocyte subpopulations in tuberculosis. Indian Pediatr 2000; 37: 489-495.
4. Martin DJ, Sim JG, Sole GJ et al. CD4 lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 386-391.
5. Swaminathan S. Tuberculosis in HIV-infected children. Paediatr Respiratory Rev 2004; 5: 225-230.
6. Palme IB, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 2002; 21: 1053-1061.
7. WHO. Management of TB in the HIV-infected child. Int J Tuberc Lung Dis 2006; 10: 1331-1336.
8. Chan SP, Birnbaum J, Rao M, Steiner P. Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1996; 15: 443-447.
9. Khouri YF, Mastrucci MT, Hutto C, Mitchell CD, Scott GB. Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 1992; 11: 950-955.
10. Gutman LT, Moye J, Zimmer B, Tian C. Tuberculosis in human immunodeficiency virus-exposed or -infected United States children. Pediatr Infect Dis J 1994; 13: 963-968.
11. Bakshi SS, Alvarez D, Hilfer CL, Sordillo EM, Grover R, Kairam R. Tuberculosis in human immunodeficiency virus-infected children. A family infection. Am J Dis Child 1993; 147: 320-324.
12. Jones DS, Malecki JM, Bigler WJ, Witte JJ, Oxtoby MJ. Pediatric tuberculosis and human immunodeficiency virus infection in Palm Beach County, Florida. Am J Dis Child 1992; 146: 1166-1170.
13. World Health Organization (WHO). Considerations for Infants and Children Coinfected with Tuberculosis and HIV. Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access. Geneva: WHO, 2006: 43-48.
14. World Health Organization (WHO). Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. Geneva: WHO, 2006.
15. World Health Organization (WHO). WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva: WHO, 2006.
16. World Health Organization (WHO). Two Diseases: One Patient. Report of the Third Global TB/HIV Working Group Meeting, Montreux. Geneva: WHO, 2003.
17. Fujiwara PI, Clevenbergh P, Dlodlo RA. Management of adults living with HIV/AIDS in low-income, high-burden settings, with special reference to persons with tuberculosis. Int J Tuberc Lung Dis 2005; 9: 946-958.
18. Walters E, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus-infected children on anti-retroviral therapy. BMC Pediatr 2008; 8: 1.
19. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: Long term incidence and risk factors in a South African cohort. AIDS 2005; 19: 2109-2116.
20. Chemtob D, Weiler-Ravell D, Leventhal A, Bibi H. Epidemiologic characteristics of pediatric active tuberculosis among immigrants from high to low tuberculosis-endemic countries: The Israeli experience. Isr Med Assoc J 2006; 8: 21-26.
21. Thomas P, Bornschlegel K, Singh TP et al. Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City. The New York City Pediatric Spectrum of HIV Disease Consortium. Pediatr Infect Dis J 2000; 19: 700-706.
22. Ampofo KK, Saiman L. Pediatric tuberculosis. Pediatr Ann 2002; 31: 98-108.
23. Graham SM, Gibb DM. HIV disease and respiratory infection in children. Br Med Bull 2002; 61: 133-150.
24. HIV Paediatric Prognostic Markers Collaborative Study. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS 2006; 20: 1289-1294.
25. Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect 2006; 53: 357-363.
26. Luetkemeyer AF, Charlebois ED, Flores LL et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007; 175: 737-742.
27. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: A prospective cohort study. Lancet 2004; 364: 2196-2203.